88239 CPT® code: payer coverage and prior authorization88239 appears in 6 coverage policies from Aetna, Blue Cross NC, Cigna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Adoptive Immunotherapy and Cellular Therapy (0641) | listed, no stance | Sep 25, 2026 | payer document |
| Aetna | Recurrent Pregnancy Loss (0348) | covered if criteria are met (range 88230-88239) | Jun 23, 2026 | payer document |
| Aetna | Tumor Chemoresistance Assays (0758) | listed, no stance | Dec 2, 2025 | payer document |
| Aetna | Tumor Chemosensitivity Assays (0245) | listed, no stance | Apr 13, 2026 | payer document |
| Blue Cross NC | General Genetic Testing, Somatic Disorders AHS - M2146 | listed, no stance | Jan 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.